| Literature DB >> 27193302 |
Gregory C Finnigan1, Sarah M Sterling1, Angela Duvalyan1, Elizabeth N Liao1, Aspram Sargsyan1, Galo Garcia1, Eva Nogales2, Jeremy Thorner3.
Abstract
Passage through the eukaryotic cell cycle requires processes that are tightly regulated both spatially and temporally. Surveillance mechanisms (checkpoints) exert quality control and impose order on the timing and organization of downstream events by impeding cell cycle progression until the necessary components are available and undamaged and have acted in the proper sequence. In budding yeast, a checkpoint exists that does not allow timely execution of the G2/M transition unless and until a collar of septin filaments has properly assembled at the bud neck, which is the site where subsequent cytokinesis will occur. An essential component of this checkpoint is the large (1518-residue) protein kinase Hsl1, which localizes to the bud neck only if the septin collar has been correctly formed. Hsl1 reportedly interacts with particular septins; however, the precise molecular determinants in Hsl1 responsible for its recruitment to this cellular location during G2 have not been elucidated. We performed a comprehensive mutational dissection and accompanying image analysis to identify the sequence elements within Hsl1 responsible for its localization to the septins at the bud neck. Unexpectedly, we found that this targeting is multipartite. A segment of the central region of Hsl1 (residues 611-950), composed of two tandem, semiredundant but distinct septin-associating elements, is necessary and sufficient for binding to septin filaments both in vitro and in vivo. However, in addition to 611-950, efficient localization of Hsl1 to the septin collar in the cell obligatorily requires generalized targeting to the cytosolic face of the plasma membrane, a function normally provided by the C-terminal phosphatidylserine-binding KA1 domain (residues 1379-1518) in Hsl1 but that can be replaced by other, heterologous phosphatidylserine-binding sequences.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27193302 PMCID: PMC4945140 DOI: 10.1091/mbc.E16-03-0177
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:Analysis of the subcellular location of a sequential series of 400-residue overlapping fragments of protein kinase Hsl1. (A) Primary structure of Hsl1. Previously characterized sequence features include the kinase (catalytic) domain (green; Shulewitz, 2000; Szkotnicki ); the putative ubiquitin association domain (blue; Hofmann and Bucher, 1996; Mueller and Feigon, 2002); the KEN box and D-box motifs (orange; Burton and Solomon, 2001); the Hsl7-binding element (gray; Shulewitz ; Crutchley ); and the KA1 domain (pink; Moravcevic ). (B) Top, diagram depicting Hsl1 and the indicated fragments that were expressed in vivo under the control of the same promoter from the same CEN vector, each as a fusion to the N-terminus of eGFP. Bottom, yeast strain GFY-42 expressing Cdc10-mCherry from its endogenous locus transformed with plasmids expressing either full-length Hsl1 (pGF-IVL521) or each of the indicated fragments (pGF-IVL561 through pGF-IVL567) and examined by fluorescence microscopy. All images were scaled identically. Arrowheads, GFP signal at the bud neck; dotted white line, cell periphery; scale bar, 2 μm. For clarity, only one or a few representative cells are shown for each construct, and the dotted white line is omitted for constructs that exhibited significant PM fluorescence.
FIGURE 2:Residues 611–950 of Hsl1 are necessary and sufficient, in conjunction with the C-terminal KA1 domain, for optimal bud neck localization. (A) Top, diagram of Hsl1 and the indicated C-terminal truncations and C-terminal fragments that were examined. Bottom, plasmids producing full-length Hsl1 (pGF-IVL521), empty vector (pRS315), or the indicated truncations and fragments (pGF-IVL522 through pGF-IVL525), expressed and visualized as in Figure 1, A and B. Arrowheads, GFP signal at the bud neck; dotted white line, cell periphery; scale bar, 2 μm. For clarity, only one or a few representative cells are shown for each construct. and the dotted white line is omitted for constructs that exhibited significant PM fluorescence. (B) Top, relative average pixel intensity of the GFP signal at the bud neck was quantified in triplicate using ImageJ. Error bars, SEM; asterisk, statistically significant difference (p < 0.05) using an unpaired t test. Bottom, relative PM fluorescence quantified as the ratio of the maximum pixel intensity of the PM signal vs. the average cytosolic fluorescence signal, measured as described in detail in Supplemental Figure S3. (C) Top, diagram of Hsl1 and the indicated N-terminal truncations and internal deletions that were examined. Bottom, plasmids producing the indicated truncations and deletions (pGF-IVL526 through pGF-IVL533), expressed and visualized as in Figure 1, A and B. Arrowheads, structures consistent with some mitochondrial localization; scale bar, 2 μm. (D) Top, diagram of the indicated internal fragments fused, where shown, to the indicated C-terminal fragments that were examined. Bottom, plasmids producing the indicated constructs (pGF-IVL534 through pGF-IVL536, left; pGF-IVL624 through pGF-IVL626, right), expressed and visualized as in Figure 1, A and B. Scale bar, 2 μm.
FIGURE 3:The 611–950 segment of Hsl1 contains two separable septin-association elements. (A) Right, diagram of the indicated internal fragments, each fused to the same C-terminal fragment (and eGFP), that were examined. Left, plasmids producing the indicated constructs (pGF-IVL536 and pGF-IVL601 through pGF-IVL611), expressed and visualized as in Figure 1, A and B. Scale bar, 2 μm. (B) Right, diagram of the same internal fragments as in A, each fused to eGFP only, that were examined. Left, plasmids producing the indicated constructs (pGF-IVL612 through pGF-IVL623), expressed and visualized as in Figure 1, A and B. Dotted white line, cell periphery; scale bar, 2 μm. For clarity, only one or a few representative cells are shown for each construct, and the dotted white line is omitted for constructs that exhibited significant PM fluorescence.
FIGURE 4:A conserved sequence element within the 611–950 segment of Hsl1 makes a major contribution to its bud neck localization. Top, diagram of the indicated internal deletions and the Hsl1(T665A L666A N668A S669A S671A K672A R673A S674A L675A Y676A S677A S680A I681A S682A K683A R684A S685A N687A L688A) allele that were examined. Bottom, plasmids producing the indicated deletions and substitution mutant (pGF-IVL666, pGF-IVL665, pGF-IVL710, pGF-IVL709, pGF-IVL711, and pGF-IVL816), expressed and visualized as in Figure 1, A and B. Arrowheads, GFP signal in PM-associated puncta; dotted white line, cell periphery; scale bar, 2 μm. For clarity, only one or a few representative cells are shown for each construct, and the dotted white line is omitted for constructs that exhibited significant PM fluorescence.
FIGURE 5:A cryptic bipartite NLS is separable from the conserved septin-associating sequence element in the 611–950 segment of Hsl1. (A) Positions of the residues mutated in the N-terminal portion (residues 611–710) of the 611–950 segment of S. cerevisiae Hsl1 aligned using ClustalW against the corresponding sequences of seven other yeast species (Sc, Saccharomyces cerevisiae; Cg, Candida glabrata; Kn, Kazachstania naganishii; Zr, Zygosaccharomyces rouxii; Zb, Zygosaccharomyces bailii; Nc, Naumovozyma castellii; Ka, Kazachstania africana; and Vp, Vanderwaltozyma polyspora). See also Supplemental Figure S2. White-on-black letters represent invariant residues across all eight fungal species; blue letters indicate strongly conserved residues (found in seven of the eight species). Pink, set 1 allele (R635A R636A K645A H648A K649A R653A K654A); green, set 2 allele (R663A R664A K672A R673A K683A R684A; blue, set 3 allele (T665A L666A N668A S669A S671A K672A R673A S674A L675A Y676A S677A S680A I681A S682A K683A R684A S685A N687A L688A). (B) Right, diagram of the indicated mutated internal fragments, either free or fused to the same C-terminal fragment (and eGFP), that were examined. Bottom, plasmids producing the indicated constructs (pGF-IVL705, pGF-IVL757, pGF-IVL758, pGF-IVL760, pGF-IVL762, pGF-IVL763, pGF-IVL765, pGF-IVL766, and pGF-IVL817 through pGF-IVL820), expressed and visualized as in Figure 1, A and B. Scale bar, 2 μm.
FIGURE 6:The 611–950 segment of Hsl1 binds directly to assembled septin filaments in vitro. (A) Diagram of the primary structure of the His6-MBP-Hsl1(611–950) fusion protein expressed in and purified from E. coli as described in Materials and Methods. (B) Cosedimentation assay. Cdc11-capped hetero-octamers, purified as described in Materials and Methods, alone (lanes 1–4), purified His6-MBP-Hsl1(611–950) alone (lanes 5–8), a 1:2 mixture of Cdc11-capped hetero-octamers and His6-MBP-Hsl1(611–950) (lanes 9–12), purified His6-MBP alone (lanes 13–16), or a 1:2 mixture of Cdc11-capped hetero-octamers and His6-MBP (lanes 17–20) were incubated in either high-salt buffer (H) or low-salt buffer (L) and then subjected to high-speed centrifugation and separated into supernatant (s) and pellet (p) fractions, the contents of which were then resolved by SDS–PAGE and analyzed by staining with InstantBlue dye. (C) Samples of the indicated mixtures from B were applied to carbon-coated copper grids, stained, and examined by EM, and representative images were recorded. Scale bar, 100 nm.
FIGURE 7:High-affinity PM binding is the sole role of the KA1 domain for localization of Hsl1 to the septin collar. (A) Top, diagram of the KA1 domains of the indicated protein kinases (white, Hsl1; pink, Gin4; and, blue, Kcc4) and the C2 domain of bovine (Bos taurus) lactadherin (orange), each fused to the C-terminus of eGFP, that were examined. Bottom, plasmids producing the indicated constructs (pGF-IVL181, pGF-IVL184, pGF-IVL187, and pGF-IVL708), expressed and visualized as in Figure 1, A and B. (B) Top, diagram of the fusions of the 611–950 segment of Hsl1 to the indicated heterologous membrane-targeting domains (and to eGFP) that were examined. Bottom, plasmids producing the indicated constructs (pGF-IVL639, pGF-IVL641 and pGF-IVL688), expressed and visualized as in Figure 1, A and B. (C) Top, diagram of the constructs in which the endogenous KA1 in Hsl1 was substituted with the indicated heterologous membrane-targeting domains (fused to eGFP). Bottom, plasmids producing the indicated constructs (pGF-IVL638, pGF-IVL640 and pGF-IVL687), expressed and visualized as in Figure 1, A and B. Dotted white line, cell periphery; scale bar, 2 μm. The dotted white line is omitted for constructs that exhibited significant PM fluorescence.
FIGURE 8:Cells lacking mih1∆ provide a sensitized background for assessment of Hsl1 function. (A) Simultaneous absence of Mih1 and Hsl1 is lethal. Strains of the BY4741 lineage expressing either Cdc10-mCherry (GFY-42) or Cdc11-mCherry (GFY-58) as indicated and carrying the wild-type HLS1 and/or MIH1 loci or carrying an hsl1∆ mutation (GFY-1156 and GFY-1157), an mih1∆ mutation (GFY-1881 and GFY-1882), or both (GFY-1737 and GFY-1738), and harboring a wild-type copy of the HSL1 gene on a URA3-marked CEN plasmid (pGFY-316-IVL924) were incubated for 2 d at 30˚C on medium lacking uracil (left) or containing 5-FOA (right) to select for the loss of the covering plasmid. (B) Toxicity of overexpressed Hsl1 is ameliorated by eliminating its kinase activity, revealing that the 611–950 segment combined with the KA1 domain is necessary and sufficient to compete for the function of endogenous Hsl1. Wild-type cells (BY4741, leftmost pair) or an otherwise isogenic mih1∆ derivative (GFY-1652, rightmost pair) were transformed with plasmids overexpressing from the GAL1/10 promoter eGFP alone (pGF-IVL391), full-length Hsl1 (fused to eGFP; pGF-IVL302), or the other indicated Hsl1 derivatives (pGF-IVL694, pGF-IVL689, pGF-IVL932, pGF-IVL642, pGF-IVL643, pGF-IVL929, pGF-IVL893A, pGF-IVL893B, pGF-IVL863, pGF-IVL894B, pGF-IVL895, pGF-IVL930, pGF-IVL896, pGF-IVL931, pGF-IVL644, pGF-IVL645, and pGF-IVL646), grown overnight at 30°C in liquid SD-Leu medium containing 2% raffinose and 0.2% sucrose, spotted onto agar plates containing SD-Leu (left) or SGal-Leu (right), and incubated at 30°C for 3 d. In two constructs, C2Lact domain was fused to the C-terminus of the Hsl1(1–374)-GFP or Hsl1(1–374; D239A) fragment, as indicated. Red asterisks, overexpressed fragments containing both the 611–950 segment and the KA1 domain cause an Hsl1-deficient phenotype in mih1∆ cells. (C) Hsl1 kinase-dead (D239A) allele localizes normally. Cells of strain GFY-42 expressing both Cdc10-mCherry from its endogenous locus and a full-length, catalytically inactive Hsl1 allele, Hsl1(D239A) (tagged with eGFP), from a plasmid (pGF-IVL693) were visualized by fluorescence microscopy. Scale bar, 2 μm.
FIGURE 9:Preventing APC-mediated degradation and blocking nuclear import of the 611–950 fragment of Hsl1 markedly enhance its ability to confer an Hsl1-deficient phenotype by displacing endogenous Hsl1 from the bud neck. (A) Wild-type cells (BY4741, leftmost pair) or an otherwise isogenic mih1∆ derivative (GFY-1652, rightmost pair) were transformed with either empty vector (pRS315) or derived plasmids overexpressing from the GAL1/10 promoter either GST alone (pGF-IVL914) or the other indicated fragments of Hsl1 fused to GST (pGF-IVL911, pGF-IVL916, pGF-IVL912, pGF-IVL917, pGF-IVL913, and pGF-IVL918), which were also tagged with a FLAG epitope at the end opposite from that fused to GST and then propagated and tested for growth as described in Figure 8B. (B) Strain GFY-1739, expressing both Cdc10-mCherry and Hsl1-GFP from their endogenous loci, was transformed with the same plasmids as in A, grown overnight to saturation in SD-Leu medium containing 2% raffinose and 0.2% sucrose, backdiluted in SD-Leu medium containing 2% galactose, incubated for 4–5 h at 30°C, and then examined by fluorescence microscopy. Arrowheads, mCherry-marked septins deposited at ectopic locations. (C) Representative cells in cultures of the same strains as in B, numbered 1–8 for clarity, that were grown overnight in SGal-Leu medium to saturation and then examined by DIC. Images were scaled identically; scale bar, 2 μm.
FIGURE 10:Two-step mechanism for localization of Hsl1 to the septin collar at the bud neck. (A) Diagram of Hsl1 with the locations of the septin-binding region (pink) pinpointed in this study and the KA1 domain (purple) highlighted. As described in the text, the 611–950 segment contains two distinct and separable septin-association elements, as well as the KEN and D-box APC recognition motifs (orange bars). Residues 611–950 are both necessary and sufficient for binding of Hsl1 to the septin filaments in the collar at the bud neck; however, for optimal and exclusive recruitment of Hsl1 to this location, interaction of the KA1 domain with the PM is required. (B) Two-stage model for efficient recruitment of Hsl1 to the septin collar. Left, at the bud neck, septin filaments are tightly associated with the PM via their binding to PtdIns4,5P2, a lipid enriched at the bud neck. The KA1 domain concentrates Hsl1 at the PM by binding to PtdSer, another lipid that is also enriched at the bud neck. Thus the most likely scenario to account for the observed synergy between the KA1 domain and the 611–950 septin-binding segment is that KA1-mediated concentration of Hsl1 at the PM permits more efficient encounter of its 611–950 septin-binding domain with the septin filaments. Right, subsequent Hsl1-dependent recruitment of Hsl7 to the bud neck promotes degradation of Swe1, a negative regulator of Clb-bound Cdk1/Cdc28, which, in conjunction with the action of the phosphatase Mih1, fully releases Cdk1 from inhibition, allowing for timely initiation of and passage through the G2/M transition of the cell cycle.
Yeast strains used in this study.
| Strain | Genotype | Reference |
|---|---|---|
| BY4741 |
| |
| GFY-42 | BY4741 |
|
| GFY-58 | BY4741 |
|
| GFY-1156 | BY4741 | This study |
| GFY-1157 | BY4741 | This study |
| GFY-1881 | BY4741 | This study |
| GFY-1882 | BY4741 | This study |
| GFY-1737a | BY4741 | This study |
| GFY-1738a | BY4741 | This study |
| GFY-1652b | BY4742 | Life Technologies |
| GFY-1739c | BY4741 | This study |
aStrains 1737 and 1738 were constructed by first switching the KanR cassette of strains GFY-1156 and GFY-1157, respectively, to NatR, followed by transformation of the pRS316-based covering vector expressing WT HSL1 (pGF-316-IVL924) and, finally, deletion of MIH1 using the knockout cassette from GFY-1652.
bAn isogenic clone was tested by multiple diagnostic PCRs from the haploid yeast genome deletion collection (Brachmann ).
cThis strain was constructed by integrating prHSL1::HSL1(WT)::GFP::Kan (amplified from pGF-IVL560) at the native HSL1 locus in GFY-1656.
Plasmids used in this study. Continued
| Plasmid | Description | Reference |
|---|---|---|
| pGF-IVL521a,b | pRS315; | This study |
| pRS315 |
| |
| pGF-IVL561 | pRS315; | This study |
| pGF-IVL562c | pRS315; | This study |
| pGF-IVL563 | pRS315; | This study |
| pGF-IVL564 | pRS315; | This study |
| pGF-IVL565 | pRS315; | This study |
| pGF-IVL566 | pRS315; | This study |
| pGF-IVL567 | pRS315; | This study |
| pGF-IVL522 | pRS315; | This study |
| pGF-IVL523 | pRS315; | This study |
| pGF-IVL524 | pRS315; | This study |
| pGF-IVL525 | pRS315; | This study |
| pGF-IVL526 | pRS315; | This study |
| pGF-IVL527 | pRS315; | This study |
| pGF-IVL528 | pRS315; | This study |
| pGF-IVL529 | pRS315; | This study |
| pGF-IVL530 | pRS315; | This study |
| pGF-IVL531 | pRS315; | This study |
| pGF-IVL532 | pRS315; | This study |
| pGF-IVL533 | pRS315; | This study |
| pGF-IVL534 | pRS315; | This study |
| pGF-IVL535 | pRS315; | This study |
| pGF-IVL536 | pRS315; | This study |
| pGF-IVL624 | pRS315; | This study |
| pGF-IVL625 | pRS315; | This study |
| pGF-IVL626 | pRS315; | This study |
| pGF-IVL601 | pRS315; | This study |
| pGF-IVL602 | pRS315; | This study |
| pGF-IVL603 | pRS315; | This study |
| pGF-IVL604 | pRS315; | This study |
| pGF-IVL605 | pRS315; | This study |
| pGF-IVL606 | pRS315; | This study |
| pGF-IVL607 | pRS315; | This study |
| pGF-IVL608 | pRS315; | This study |
| pGF-IVL609 | pRS315; | This study |
| pGF-IVL610 | pRS315; | This study |
| pGF-IVL611 | pRS315; | This study |
| pGF-IVL612 | pRS315; | This study |
| pGF-IVL613 | pRS315; | This study |
| pGF-IVL614 | pRS315; | This study |
| pGF-IVL615 | pRS315; | This study |
| pGF-IVL616 | pRS315; | This study |
| pGF-IVL617 | pRS315; | This study |
| pGF-IVL618 | pRS315; | This study |
| pGF-IVL619 | pRS315; | This study |
| pGF-IVL620 | pRS315; | This study |
| pGF-IVL621 | pRS315; | This study |
| pGF-IVL622 | pRS315; | This study |
| pGF-IVL623 | pRS315; | This study |
| pGF-IVL665 | pRS315; | This study |
| pGF-IVL666 | pRS315; | This study |
| pGF-IVL709 | pRS315; | This study |
| pGF-IVL710 | pRS315; | This study |
| pGF-IVL711 | pRS315; | This study |
| pGF-IVL816d | pRS315; | This study |
| pGF-IVL 765d | pRS315; | This study |
| pGF-IVL 766d | pRS315; | This study |
| pGF-IVL818d | pRS315; | This study |
| pGF-IVL762d | pRS315; | This study |
| pGF-IVL763d | pRS315; | This study |
| pGF-IVL817d | pRS315; | This study |
| pGF-IVL705d | pRS315; | This study |
| pGF-IVL760d | pRS315; | This study |
| pGF-IVL820d | pRS315; | This study |
| pGF-IVL757d | pRS315; | This study |
| pGF-IVL758d | pRS315; | This study |
| pGF-IVL819d | pRS315; | This study |
| pGF-IVL638e | pRS315; | This study |
| pGF-IVL639e | pRS315; | This study |
| pGF-IVL640e | pRS315; | This study |
| pGF-IVL641e | pRS315; | This study |
| pGF-IVL181e | pRS315; | This study |
| pGF-IVL184e | pRS315; | This study |
| pGF-IVL187 | pRS315; | This study |
| pGF-IVL687f | pRS315; | This study |
| pGF-IVL688f | pRS315; | This study |
| pGF-IVL708f | pRS315; | This study |
| pGFY-316-IVL924g | pRS316; | This study |
| pGF-IVL693 | pRS315; | This study |
| pGF-IVL391 | pRS315; | This study |
| pGF-IVL302h | pRS315; | This study |
| pGF-IVL694i | pRS315; | This study |
| pGF-IVL689 | pRS315; | This study |
| pGF-IVL932 | pRS315; | This study |
| pGF-IVL642 | pRS315; | This study |
| pGF-IVL643 | pRS315; | This study |
| pGF-IVL929 | pRS315; | This study |
| pGF-IVL893A | pRS315; | This study |
| pGF-IVL893B | pRS315; | This study |
| pGF-IVL863 | pRS315; | This study |
| pGF-IVL894B | pRS315; | This study |
| pGF-IVL895 | pRS315; | This study |
| pGF-IVL930 | pRS315; | This study |
| pGF-IVL896f | pRS315; | This study |
| pGF-IVL931f | pRS315; | This study |
| pGF-IVL645 | pRS315; | This study |
| pGF-IVL644 | pRS315; | This study |
| pGF-IVL646 | pRS315; | This study |
| pGF-IVL914j | pRS315; | This study |
| pGF-IVL911k,l | pRS315; | This study |
| pGF-IVL916 | pRS315; | This study |
| pGF-IVL912 | pRS315; | This study |
| pGF-IVL917 | pRS315; | This study |
| pGF-IVL913 | pRS315; | This study |
| pGF-IVL918 | pRS315; | This study |
| p42m | 2E; | This study |
| pXSMS001n | pHM3C-LIC; | This study |
| pXSMS008n | pHM3C-LIC; | This study |
aFor clarity, rather than present the deleted residues, the numbering system for alleles of HSL1 presents the amino acid resides still present within the final protein sequence.
bFor variants of Hsl1 that include the CDC11 promoter and are C-terminally tagged with eGFP::Kan, the following construction strategy was used to aid in plasmid generation. First, a parent vector (pGF-IVL520) was generated that contained prCDC11::eGFP::Kan with a unique NotI restriction site between the promoter sequence and the first codon of eGFP. In vivo ligation and homologous transformation was used to gap repair the linearized parent vector to insert the fragment(s) of HSL1 sequence. In addition, due to the large size of the HSL1 gene, multiple PCRs were often generated containing a significant amount (several hundred bases) of homology to link adjacent fragments.
cFor Hsl1 constructs that did not include the native N-terminal sequence of Hsl1 (such as pGF-IVL562), a start codon was included within the parent vector (pGF-IVL520); the numbering scheme excludes this initiator Met residue.
dSuccessive rounds of a modified QuikChange PCR mutagenesis protocol (Zheng ) were performed on a fragment of Hsl1(611-950) subcloned into a TOPO-II vector (pGF-V672; Life Technologies) to mutate the desired residues to alanine before creation of the final yeast vector using in vivo ligation and homologous recombination.
eThe KA1 domains Gin4(1003-1142) and Kcc4(877-1037) were defined as previously described (Moravcevic ).
fThe Bos taurus lactadherin C2 (Lact-C2) domain (Shao ) was fused to each construct on the C-terminus of eGFP. The numbering scheme for Lact-C2 refers to the specific domain and not the full-length lactadherin protein. The template DNA used to amplify the Lact-C2 domain is plasmid 22853 (Addgene, Cambridge, MA).
gThe URA3-based covering vector expressing WT HSL1 was constructed by first constructing prHSL1::HSL1(1-1518)::SHS1(3′UTR) in a pRS315 vector containing a unique NotI restriction site downstream of the SHS1 3′ UTR sequence and the NatR cassette (pGF-IVL924). The HSL1 cassette was then subcloned to pRS316 (NotI/SpeI sites).
hFor plasmids expressing Hsl1 under control of the GAL1/10 promoter and C-terminally tagged with eGFP::SpHIS5, a parental vector was first constructed (pGF-IVL300), which included the GAL1/10 promoter linked to eGFP::SpHIS5 on pRS315 with a unique NotI restriction site. In vivo ligation and homologous recombination were used to insert the desired HSL1 fragment(s) into this vector.
iFor alleles of Hsl1 that included point mutation(s), a modified QuikChange protocol (Zheng ) was used to generate the appropriate substitutions on fragments of Hsl1 subcloned into a TOPO-II vector (Life Technologies) before PCR amplification for plasmid construction. Multiple substitutions, such as in pGF-IVL821, were performed by successive rounds of QuikChange PCR.
jThe GST tag was amplified from vector pJT4649 in constructs pGF-IVL911 to pGF-IVL914 and pGF-IVL916 to pGF-IVL918 and ends with the amino acid sequence PGIHRDGG in each of the aforementioned vectors.
kThe single FLAG epitope tag has the sequence DYKDDDDK in vectors pGF-IVL911 to pGF-IVL913 and pGF-IVL916 to pGF-IVL918 and was inserted using in vivo ligation.
lThe Hsl1 vectors pGF-IVL911, pGF-IVL912, pGF-IVL916, and pGF-IVL917, which contain the fragment from residue 611–950, also contain the mutations to disrupt the putative NLS signal (R635A R636A K645A H648A K649A R653A K654A), as well as both the KEN and D-box motifs (K775A E776A N777A R828A L831A). The constructs were assembled using in vivo ligation and used pGF-IVL762 and pGF-IVL654 as templates to combine all of the necessary mutations and fragments.
mAddgene vector 29775, provided by Scott Gradia at the QB3 Macrolab, University of California, Berkeley. This vector includes a kanamycin resistance gene.
nBoth vectors contain the kanamycin resistance gene. In addition, the PreScission cleavage site included after the MBP sequence is from the human rhinovirus 3C protease cleavage site with the sequence LEVLFQGP. For plasmid pXSMS008, a STOP codon was mutated within the first codon of the Hsl1 sequence.